S
Silexion Therapeutics Corp (SLXN)
NCM – Real Time Price. Currency in USD
0.58
+0.07 (14.20%)
At close: May 12, 2026, 4:00 PM EDT
0.58
+0.00 (0.69%)
After-hours: May 12, 2026, 7:12 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.58
+0.07 (14.20%)
At close: May 12, 2026, 4:00 PM EDT
0.58
+0.00 (0.69%)
After-hours: May 12, 2026, 7:12 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $6.0M significantly exceed its total debt $2.0M, ensuring strong financial flexibility
Total current assets $6.6M exceed Total current liabilities $2.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.8) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$3.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.41 | 6.05 | 10 | |
| Quick ratio | 2.41 | 5.63 | 10 | |
| Debt to Equity | 0.78 | 0.30 | 6.0 | |
| Debt to Assets | 0.28 | 1.04 | 7.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | -45K | -25K | -14K | -14K |
| Operating Income | -1M | -5M | -13M | -12M | -12M |
| Net Income | 584K | -5M | -16M | -12M | -12M |
| EBITDA | -1M | -5M | -13M | -12M | -12M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 66.92 | 5.5 |
| Next quarter | N/A | 69.68 | 5.5 |
| Current year | N/A | 54.02 | 5.5 |
| Next year | N/A | 45.87 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -35.24 | 17.19 | -6.15 | 5.3 |
| Y/Y | 999 | -152.54 | 79.35 | -3.13 | 5.5 |
| 3y average | 999 | -383.77 | N/A | -256.72 | 3.3 |
| 5y average | 999 | -251.91 | N/A | -477.68 | 3.3 |
| Weighted average score | 4.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |